Olinciguat
Olinciguat (IW-1701) is a soluble guanylate cyclase stimulator that was in development for sickle cell anemia.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Olinciguat (IW-1701) is a soluble guanylate cyclase stimulator that was in development for sickle cell anemia. After receiving orphan drug status in 2018 and completing a phase II trial, its development for sickle cell anemia was discontinued in 2020.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1358317540 under CC BY-SA 4.0; modifications have been made.